HT-1Hereditary Tyrosinemia Type 1
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
"The HT-1 patient journey - from early screening and diagnosis, to improved medical care associated with continuous higher survival rates - has driven Sobi's commitment to develop new strengths and formulations for Orfadin to continually meet the medical needs of HT-1 patients", says Michael Yeh, Vice President Medical Affairs.
As more countries introduce newborn screening for HT-1, infants are diagnosed earlier in life.
People with Hereditary Tyrosinaemia type-1 (HT-1) have problems breaking down an amino acid called tyrosine.